Farms.com Home   News

CN Marks Record December, Annual Grain Movement

Canadian National Railway set a new benchmark for grain movement in December, capping off a record-breaking year.  

The railway said Friday it moved more than 2.82 million tonnes of grain from Western Canada in December, marking its fourth consecutive monthly record and surpassing the previous December high set in 2020 by more than 80,000 tonnes. 

The strong December performance also helped CN establish a new annual record for grain shipments in 2025. In Western Canada alone, CN moved over 31.3 million tonnes of grain during the year, exceeding the previous record of 30.9 million set in 2020. Across all of Canada, total grain volumes across CN’s network reached more than 32.7 million tonnes, breaking the prior record of 32.25 million established in 2024. 

CN attributed the record volumes to a combination of large Canadian grain crops and steady execution throughout the supply chain.  

Janet Drysdale, CN’s executive vice-president and chief commercial officer, said consistent operations and close collaboration with farmers, grain companies and export terminals were key to moving the unprecedented volumes to market. 

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.